期刊
CANCER SCIENCE
卷 109, 期 8, 页码 2342-2348出版社
WILEY
DOI: 10.1111/cas.13655
关键词
enhancer of zeste homolog 1 and 2; epigenetics; histone methyltransferase; polycomb repressive complexes; transcriptional repression
类别
资金
- Acceleration Transformative Research for Medical Innovation from the Japan Agency for Medical Research and Development
- National Cancer Center Research and Development Fund
Polycomb group (PcG) proteins regulate the expression of target genes by modulating histone modifications and are representative epigenetic regulators that maintain the stemness of embryonic and hematopoietic stem cells. Histone methyltransferases enhancer of zeste homolog 1 and 2 (EZH1/2), which are subunits of polycomb repressive complexes (PRC), are recurrently mutated or highly expressed in many hematological malignancies. EZH2 has a dual function in tumorigenesis as an oncogene and tumor suppressor gene, and targeting PRC2, in particular EZH1/2, for anticancer therapy has been extensively developed in the clinical setting. Here, we review the oncogenic function of EZH1/2 and introduce new therapeutic drugs targeting these enzymes.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据